ProPhase Labs (NASDAQ:PRPH) Now Covered by Analysts at StockNews.com

Analysts at StockNews.com started coverage on shares of ProPhase Labs (NASDAQ:PRPHGet Free Report) in a research report issued on Tuesday. The brokerage set a “sell” rating on the stock.

ProPhase Labs Stock Up 0.0 %

PRPH stock opened at $0.53 on Tuesday. The company has a 50 day moving average of $0.53 and a two-hundred day moving average of $1.44. The company has a market cap of $12.75 million, a price-to-earnings ratio of -0.42 and a beta of -0.37. ProPhase Labs has a 12-month low of $0.22 and a 12-month high of $7.48. The company has a quick ratio of 1.33, a current ratio of 1.47 and a debt-to-equity ratio of 0.48.

Institutional Investors Weigh In On ProPhase Labs

Hedge funds and other institutional investors have recently made changes to their positions in the company. SVB Wealth LLC acquired a new stake in ProPhase Labs in the fourth quarter valued at approximately $36,000. Squarepoint Ops LLC acquired a new stake in shares of ProPhase Labs in the 4th quarter valued at $40,000. Warberg Asset Management LLC bought a new stake in ProPhase Labs in the fourth quarter worth $77,000. Perritt Capital Management Inc increased its position in ProPhase Labs by 129.1% during the fourth quarter. Perritt Capital Management Inc now owns 190,000 shares of the company’s stock worth $144,000 after buying an additional 107,068 shares during the last quarter. Finally, Geode Capital Management LLC increased its position in ProPhase Labs by 26.6% during the fourth quarter. Geode Capital Management LLC now owns 203,528 shares of the company’s stock worth $154,000 after buying an additional 42,793 shares during the last quarter. 9.45% of the stock is owned by hedge funds and other institutional investors.

ProPhase Labs Company Profile

(Get Free Report)

ProPhase Labs, Inc develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a range of TK supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster.

Recommended Stories

Receive News & Ratings for ProPhase Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProPhase Labs and related companies with MarketBeat.com's FREE daily email newsletter.